Sayed Douaa M, el-Attar Madiha M, Hussein Aliaa A R Mohamed
Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Diagn Cytopathol. 2009 Jul;37(7):498-504. doi: 10.1002/dc.21047.
The serosal cavities are frequent sites of tumor metastasis. The distinction between carcinoma cells, inflammatory cells, and reactive or malignant mesothelial cells can be difficult in cytology. Multicolor flow cytometry (FCM) provides the opportunity to evaluate multiple antigens simultaneously, making it possible to characterize various cell populations. In this study, we aimed to assess the diagnostic accuracy of FCM immunophenotyping and DNA in comparison with serum tumor markers and classic cytology for detection of malignant cells in pleural and ascitic fluids. One hundred and nineteen samples of body cavity fluids were analyzed. Immunophenotyping was performed by four-color immunofluorescent staining using monoclonal antibodies against Ber-EP4, cytokeratin, CD3, and CD45. The DNA analysis by FCM was also performed. In addition, serum CA19-9, CEA, AFP, and CA125 were analyzed. Ber-EP4 marker had the highest sensitivity (73%) and specificity (95.5%) in the detection of carcinoma cells in serous fluid and correlated with cytology in most of cases (73%). The mean of DI differed statistically in patients with malignant effusions than in benign one. DI showed no difference in fluids due to infiltration of malignant epithelial cells or hematopoietic malignancy or due to hepatocellular carcinoma developing in cirrhotic liver. Thus, flow cytometry appears to aid not only in the detection of malignant cells but also in the characterization of cell type. On the other hand, although DNA ploidy examination had better sensitivity; it had no advantage over conventional cytopathological examination in identification of malignant cells.
浆膜腔是肿瘤转移的常见部位。在细胞学检查中,区分癌细胞、炎症细胞以及反应性或恶性间皮细胞可能具有一定难度。多色流式细胞术(FCM)提供了同时评估多种抗原的机会,从而能够对不同细胞群体进行特征描述。在本研究中,我们旨在评估FCM免疫表型分析和DNA检测在与血清肿瘤标志物及经典细胞学检查相比时,对检测胸腔和腹腔积液中恶性细胞的诊断准确性。对119份体腔液样本进行了分析。通过使用抗Ber-EP4、细胞角蛋白、CD3和CD45的单克隆抗体进行四色免疫荧光染色来进行免疫表型分析。同时也通过FCM进行了DNA分析。此外,还分析了血清CA19-9、癌胚抗原(CEA)、甲胎蛋白(AFP)和CA125。Ber-EP4标志物在检测浆液性积液中的癌细胞时具有最高的敏感性(73%)和特异性(95.5%),并且在大多数病例(73%)中与细胞学检查结果相关。恶性胸腔积液患者的DNA指数(DI)平均值与良性胸腔积液患者相比具有统计学差异。在因恶性上皮细胞浸润、血液系统恶性肿瘤或肝硬化肝脏中发生肝细胞癌导致的积液中,DI没有差异。因此,流式细胞术似乎不仅有助于检测恶性细胞,还能对细胞类型进行特征描述。另一方面,尽管DNA倍体检查具有更高的敏感性,但在识别恶性细胞方面,它并不比传统细胞病理学检查更具优势。